Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Promising clinical results for lamivudine in hepatitis

Nov. 15, 1996

Provir effective in acute diarrhea

Nov. 15, 1996

Therapeutic effect of Lilly antioxidant demonstrated in rat model of IBD

Nov. 15, 1996

Roberts to license Lilly gastrointestinal compounds

Nov. 15, 1996

New 5-HT3/5-HT4 antagonists from Synthelabo

Nov. 15, 1996

Anti-H. pylori agents disclosed by Shiseido

Nov. 15, 1996

Natural anti-H. pylori compounds described by Terumo

Nov. 15, 1996

Approval recommended for primary biliary cirrhosis Rx

Nov. 8, 1996

Patent coverage for new HBV treatment licensed to Vion

Nov. 8, 1996

Rabeprazole + amoxicillin for eradication of H. pylori

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...